series-c-plus
Stage
2
Investors
About
Mitralign developed a minimally invasive medical device technology intended to treat mitral valve regurgitation by reshaping the heart's mitral valve annulus.
Explore Mitralign's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.